The objective of the present investigation was to improve the solubility and the dissolution rate of Fenofibrate (FNO), a poorly water-soluble drug by solid dispersion technique using a water-soluble carrier, Poloxamer 407 (POL). The layophillization technique was used to prepare solid dispersions. A 3 2 full factorial design approach was used for optimization wherein the amount of Poloxamer 407(mg) (X 1 ) and the Lyophilization Temperature ( 0 C) (X 2 ) were selected as independent variables and the T 100% (min) and angle of repose was selected as the dependent variable. Multiple linear regression analysis revealed that for obtaining higher dissolution of FNO from POL solid dispersions, a high amount of Poloxamer 407 and a lower freeze drying temperature of were suitable. The differential scanning calorimetry and x-ray diffraction studies demonstrated that enhanced dissolution of FNO from solid dispersion might be due to a decrease in the crystallinity of FNO in lyophilized POL during solid dispersion preparation. Dissolution enhancement of FNO was obtained by preparing its solid dispersions in POL using layophillization technique. The use of a factorial design approach helped in identifying the critical factors in the preparation and formulation of solid dispersion.
Introduction
The poorly water-soluble drugs often show an erratic dissolution profile in gastrointestinal fluids, which consequently results in variable oral bioavailability and low absorption rate 1 . To improve the dissolution and bioavailability of poorly soluble drugs, researchers have employed various techniques, such as micronization, solubilization, salt formation, complexation with polymers, change in physical form, use of prodrug and drug derivatization, alteration in pH, addition of surfactants, and others 2, 3 . Chiou and Rigelman and Serajuadin et al 4, 5 have used the solid dispersion technique for dissolution enhancement of poorly water-soluble drugs. Among the various approaches, the solid dispersion technique has often proved to be the most successful in improving the dissolution and bioavailability of poorly soluble active pharmaceutical ingredients because it is simple, economic, and advantageous 6 . Sekiguchi and Obi 7 were the first to propose the solid dispersion method using water-soluble carriers to improve the dissolution characteristics of poorly water-soluble drugs.
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In this method, the drug is thoroughly dispersed in a water-soluble carrier by melting, solvent, or solventmelting methods 4 . Many water-soluble carriers have been employed for preparation of solid dispersion of poorly soluble drugs. The most common are polyethylene glycols 8, 9 , polyvinyl pyrrolidone 10, 11 , lactose 12 , β-cyclodextrin 13, 14 and hydroxypropyl methylcellulose 15 . Recently, Poloxamer, a group of block copolymer nonionic surfactants, have attracted considerable attention for application in preparation of solid dispersions 16, 17, 18 . These polymers are widely used as emulsifiers, solubilizing agents, and suspension stabilizers in liquid, oral, topical, and parenteral dosage forms and also act as wetting agents and plasticizers, and have been reported for enhancing the solubility and bioavailability of sparingly soluble drugs in solid dosage forms 19, 20 .
Nine grades of Poloxamer have been evaluated by Saettone and coworkers 21 as solubilizers for tropicamide, a poorly water-soluble drug. Solubility was found to increase as the oxyethylene content increased. Poloxamer 407 (POL) is a nonionic block copolymer chain and has been used by researchers to increase the aqueous solubility of poorly watersoluble drugs 22, 23, 24 . POL was thus selected as a carrier for dissolution enhancement of a poorly water-soluble drug.
A 3 2 full factorial design approach was used for optimization of process variables on dissolution characteristics. The aim of the present work was to study the joint influence of the independent variables the amount of Poloxamer 407(mg) (X 1 ) and the Lyophilization Temperature ( 0 C) (X 2 ) on the dependent variables the T 100% (min) and angle of repose. Physicochemical characterization was performed to evaluate the occurrence of chemical interaction between the drug and carrier molecule.
MATERIALS AND METHODS Materials
Fenofibrate (99% purity) was obtained from Cadila Pharmaceuticals Ltd, India. Poloxamer 407 (Pluronic F127) was obtained from BASF (Mount Olive, NJ, USA). Sodium hydroxide and polyoxyethylene sorbitan monooleate (Tween 80) were purchased from Sigma (UK). Other excipients used were of analytical grade. All chemicals were used as received.
Preparation of solid dispersions
Poloxamer 407 and Fenofibrate were dissolved in a minimum amount of Chloroform. This solution was rapidly solidified by transferring small portions with a Pasteur pipette onto the inner surface of a cold flask rotating in a -50°C methanol bath. After a certain layer thickness was obtained, the flask was attached to the vacuum adapter of the lyophilizer. The solvent was sublimed under a pressure of 8-10 mmHg and condensed onto a -50 0 C/-60°C/-70 0 C condenser. After the solvent was completely removed, the powder residue appeared as a porous, light and fluffy mass. The lyophilized preparations were stored in a dessicator at room temperature. The pulverized mass was sifted through a #120 sieve, weighed, and transferred to amber colored Type-I glass vials, stored at 30 0 C ± 1 0 C and the yield was determined using following formula:
where, a is the weight of the solid dispersion sifted through a #120 sieve, b is the weight of FNO taken for solid dispersion preparation, and c is the weight of POL taken for solid dispersion preparation. A 3 2 full factorial design was employed to systematically study the joint influence of the effect of independent variables X 1 and X 2 on the dependent variable. In this design, 2 factors are evaluated, each at 3 levels, and experimental trials are performed at all 9 possible combinations. A statistical model incorporating interactive and polynomial terms is used to evaluate the response. Where, Y is the dependent variable, b 0 is the arithmetic mean response of the nine runs, and b i is the estimated coefficient for the factor X i . The main effects (X 1 and X 2 ) represent the average result of changing one factor at a time from its low to high value. The interaction terms (X 1 X 2 ) show how the response changes when 2 factors are simultaneously changed. The polynomial terms (X 21 and X 22 ) are included to investigate nonlinearity. The composition of the factorial design batches are shown in Table 1 . Table  2 shows actual values of independent variables and levels of independent factors.
Experimental design

In-Vitro Dissolution Study
An ELECTROLAB dissolution test apparatus type II (Paddle) at rotation speed of 50 rpm was used for the study. Dissolution of the drug and solid dispersion was carried out on an equivalent of 100 mg of the Fenofibrate in 0.1 M SLS as dissolution media. The volume and temperature of the dissolution media were 900 ml and 37 ± 0.2 0C, respectively. After fixed time intervals, 5 ml of samples were withdrawn and replace the same fresh dissolution media so as to maintain sink condition. The samples were filters through 0.2µm filters and diluted with HPLC mobile phase and these samples were assayed HPLC at 286 nm. To increase the reliability of the observations, the dissolution studies were performed in triplicate. Differential scanning calorimetry studies Thermal properties of the untreated drug and the prepared solid dispersion were analyzed by DSC (TA Instruments, USA, and Model: LST 2960). The samples were heated in a hermetically sealed aluminum pans. Heat runs for each sample were set from 30 to 350 0 C at a heating rate of 10 0 C/ min, using nitrogen as blanket gas.
FT-IR Studies
FT-IR spectra of prepared Lyophilized solid dispersion were recorded on Shimadzu FT IR -8400 spectrophotometer (Shimadzu Corporation, Kyoto, Japan). Potassium bromide pellet method was employed and background spectrum was collected under identical situation. Each spectrum was derived from single average scans collected in the region 400 -4000 cm -1 at spectral resolution of 2 cm -2 and ratio against background interferogram. Spectra were analyzed by software supplied by Shimadzu. Figure 2 shows that T 100 % was increased as the amount of Poloxamer 407 was increased at the fix value of Lyophilization temperature (-50 0 C) might be due to hydrophilic nature of Poloxamer 407 which converted crystalline Fenofibrate in to amorphous form. As the Lyophilization temperature decreases, T 100% was decreased at the fix value of Poloxamer 407 (80 mg). Result suggested that presence of Poloxamer 407 and Lyophilization temperature is essential in achieving desired T 100%. The relationship between the dependent and independent variables was further elucidated using contour plots. Logically it was predefined to obtain the values of the T 100% = 30 minutes for the formulated products. In contour plot only formulation F9 had T 100% near to desired T 100% (Figure 2 ). It was arbitrarily decided to obtain the values of the angle of repose less than 30 0 from the formulated products. In Equation (2) Figure 3 showed that as the amount of Poloxamer 407 increase, angle of repose was increase at the fix value of Lyophilization temperature (-50 0 C). As the Lyophilization temperature increase, angle of repose was decrease at the fix value of Poloxamer 407 (80 mg).
X-ray powder diffraction analysis
The relationship between the dependent and independent variables was further elucidated using contour plots. Here, arbitrarily predefined to obtain the values of the angle of repose less than 30 minutes from the formulated products. In contour plot only formulation F9 showed angle of repose near to desired angle of repose (Figure 3) . The final selection of the optimized batch would be done after considering the other requirements of the dosage form, i.e.T 100%.
FT-IR Studies
The FT-IR spectrum of Fenofibrate, Poloxamer 407, and lyophilized solid dispersion is shown in Figure  4 IR-spectra of Fenofibrate and solid dispersion are exactly same, and there is no shift of peaks after adsorption of drug onto polymer and surfactants surface; indicating that there is no change in chemical structure of drug after preparing it into lyophilized solid dispersion Differential scanning calorimetry studies Figure 5 shows the DSC study of Fenofibrate and Fenofibrate solid dispersions. The corresponding melting point depressions, enthalpy of fusion and degree of crystallinity are shown in figure. A depression in melting point of Fenofibrate was found in solid dispersions, which indicates an interaction of Fenofibrate with carrier molecule Poloxamer 407. The DSC thermograph of Fenofibrate lyophilized formulation shows only endothermic peak; the absence of exothermic re-crystallization peak may be attributed to interaction between drug and polymers.
X-ray powder diffraction analysis
Fenofibrate crystals show various diffraction peaks (figure 6) due to its crystalline structure. However, the lyophilized solid dispersion shows a loss of drug Crystallinity due to drug loading onto polymers and surfactants surface. In optimized lyophilized solid dispersion, a few less intense and wide diffraction peaks of Fenofibrate was observed, which may be attributed to the adsorption process in which some of amorphous drug may have crystallized due to higher temperature. The sharp drug peaks corresponding to drug are absent in the lyophilized solid dispersion. The PXRD patterns of Fenofibrate, Poloxamer 407, and lyophilized solid dispersion showed a total 13, 10, and 22 peaks, respectively. The PXRD of solid dispersion exhibits 17 peaks less than the sum of the number of peaks of Fenofibrate and Poloxamer 407 in their pure forms. This suggests that Crystallinity of both drug and polymer is reduced in the lyophilized solid dispersion. Decrease in Crystallinity of the drug and polymer may contribute to enhancement of dissolution of the drug. 
Conclusions
The results of the experimental study show that the factors amount of Poloxamer 407 (X 1 ) and Lyophilization temperature (X 2 ) significantly influences the dependent variable T 100% and Angle of repose. As the Lyophilization temperature was decreased there was increase in amorphous nature of the solid dispersion of drug and due to that there will be increase in solubility of drug and ultimately oral absorption of the drug. Characterization studies revealed that Lyophilization of solid dispersion of Fenofibrate-Poloxamer 407 showed enhancement of Fenofibrate dissolution due to the conversion of Fenofibrate into a less crystalline and/or amorphous form. The application of experimental design techniques for optimization of formulation helps in reaching the optimum point in the shortest time with minimum efforts.
